Pharmacological Defibrillation and Its Mechanism in Atrial Fibrillation. The Efficacy of a Pure Class III Agent Dofetilide as Compared With Class I Antiarrhythmic Agents.

Japanese Journal of Electrocardiology
doi 10.5105/jse.18.333
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Japanese Society of Electrocardiology

Related search

Effects of E-4031 on Atrial Fibrillation Threhold: A Comparative Study With Class I Antiarrhythmic Drugs.

Japanese Journal of Electrocardiology
1994English

Class 1C Antiarrhythmic Drugs in Atrial Fibrillation and Coronary Artery Disease

Journal of Cardiovascular Electrophysiology
Cardiovascular MedicinePhysiologyCardiology
2020English

BW A256C, a Chemically Novel Class 1 Antiarrhythmic Agent. A Comparison of in Vitro and in Vivo Activity With Other Class 1 Antiarrhythmic Agents

British Journal of Pharmacology
Pharmacology
1986English

Recent Findings on the Dromotropic Actions of the Class III Antiarrhythmic Agents.

Folia Pharmacologica Japonica
Pharmacology
2002English

Effects of Sematilide, a Novel Class III Antiarrhythmic Agent, on Delayed Rectifier K+ Current in Guinea Pig Atrial Myocytes.

The Japanese Journal of Pharmacology
1996English

Antiarrhythmic Effects of Combining Dofetilide and Ranolazine in a Model of Acutely Induced Atrial Fibrillation in Horses

Journal of Cardiovascular Pharmacology
Cardiovascular MedicinePharmacologyCardiology
2018English

Schiff Bases as Important Class of Pharmacological Agents

Journal of Pharmacy and Pharmacology
2018English

"Early" Class III Drugs for the Treatment of Atrial Fibrillation: Efficacy and Atrial Selectivity of AVE0118 in Remodeled Atria of the Goat

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Absence of Effects of Class III Antiarrhythmic Agents on Cloned Cardiac K Channels.

The Japanese Journal of Pharmacology
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy